Main > ONCOLOGY (**) > Esophageal>Non Squamous>MET > TREAT.: > USA. B. PD-1 Binding MAb+

---

USA. B. PD-1 Binding MAb+'s subsections
(*) EU CE Mark Date: 2021. 10.21
(*) USA Approval Date: 2021. 04.16
+CT
Company
Generic Name: nivolumab
RTM
RTM Web-Site

USA. B. PD-1 Binding MAb+'s products
This section has no products